Literature DB >> 31562211

A Caspase-1 Biosensor to Monitor the Progression of Inflammation In Vivo.

Sarah Talley1, Olga Kalinina2, Michael Winek3, Wonbeom Paik2, Abigail R Cannon1, Francis Alonzo2, Mashkoor A Choudhry1, Katherine L Knight2, Edward M Campbell4,2,3.   

Abstract

Inflammasomes are multiprotein complexes that coordinate cellular inflammatory responses and mediate host defense. Following recognition of pathogens and danger signals, inflammasomes assemble and recruit and activate caspase-1, the cysteine protease that cleaves numerous downstream targets, including pro-IL-1β and pro-IL-18 into their biologically active form. In this study, we sought to develop a biosensor that would allow us to monitor the initiation, progression, and resolution of inflammation in living animals. To this end, we inserted a known caspase-1 target sequence into a circularly permuted luciferase construct that becomes bioluminescent upon protease cleavage. This biosensor was activated in response to various inflammatory stimuli in human monocytic cell lines and murine bone marrow-derived macrophages. Next, we generated C57BL/6 transgenic mice constitutively expressing the caspase-1 biosensor. We were able to monitor the spatiotemporal dynamics of caspase-1 activation and onset of inflammation in individual animals in the context of a systemic bacterial infection, colitis, and acute graft-versus-host disease. These data established a model whereby the development and progression of inflammatory responses can be monitored in the context of these and other mouse models of disease.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31562211     DOI: 10.4049/jimmunol.1900619

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  A comprehensive guide to studying inflammasome activation and cell death.

Authors:  Rebecca E Tweedell; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  Nat Protoc       Date:  2020-09-07       Impact factor: 13.491

2.  DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod.

Authors:  Sarah Talley; Rasa Valiauga; Lillian Anderson; Abigail R Cannon; Mashkoor A Choudhry; Edward M Campbell
Journal:  J Neuroinflammation       Date:  2021-11-10       Impact factor: 8.322

3.  Monitoring of inflammation using novel biosensor mouse model reveals tissue- and sex-specific responses to Western diet.

Authors:  Sarah Talley; Raiza Bonomo; Chaitanya Gavini; Jomana Hatahet; Emily Gornick; Tyler Cook; Byeong Jae Chun; Pete Kekenes-Huskey; Gregory Aubert; Edward Campbell; Virginie Mansuy-Aubert
Journal:  Dis Model Mech       Date:  2022-06-24       Impact factor: 5.732

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.